In a first, AstraZeneca admits its Covid vaccine Covishield can cause rare side effects
For the first time, AstraZeneca has admitted in court documents that its COVID-19 vaccine, sold globally under the brand names Covishield and Vaxzevria among others, may lead to a rare side effect.
According to media reports, the admission was made in a legal document submitted to the UK High Court in February.
According to media reports, several families filed complaints in court alleging that the AstraZeneca vaccine’s side effects have had devastating effects.
The company stated in the document that a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS) can happen even if there is no vaccination, adding that expert testimony will be required to determine causation in every individual case. It said, “It is admitted that the AZ vaccine can, in very rare cases, cause TTS. The causal mechanism is not known.”
The Cambridge-headquartered British-Swedish multinational pharmaceutical and biotechnology company now faces a class-action lawsuit, which claims that its vaccine caused serious injuries and fatalities.
The lawsuit was started last year by Jamie Scott, a father of two, who suffered a permanent brain injury by TTS after being administered the AstraZeneca vaccine in April 2021.
Developed in collaboration with the University of Oxford, AstraZeneca’s vaccine was manufactured in India by Pune-based Serum Institute of India (SII).
For all the latest updates, download PGurus App.
- Swati Maliwal assault row: New video from Arvind Kejriwal’s residence goes viral - May 17, 2024
- UN raises India’s 2024 growth rate to 6.9%; says India has become an alternative investment source for West - May 17, 2024
- Mumbai hoarding collapse case: Mumbai Police arrest owner of advertising firm from Udaipur after massive manhunt - May 17, 2024
Rare admission, but common admission